Clinical Trials
11 trialsNCT07300514 2026-03-31
T-START-M1
Fudan University
Phase 3 Recruiting
NCT07414758 2026-02-24
T-START-M1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3 Recruiting
NCT07258680 2025-12-02
BrEto-TCL
N.N. Petrov National Medical Research Center of Oncology
Phase 3 Enrolling by invitation
NCT01796002 2023-01-10
Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
The Lymphoma Academic Research Organisation
Phase 3 Completed
NCT04880746 2021-05-11
Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study
Ruijin Hospital
Phase 3 Unknown
NCT03952572 2019-05-16
Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma
Peking University
Phase 3 Unknown
NCT00646854 2019-03-01
ACT-1
University of Aarhus
Phase 3 Completed
NCT03355768 2018-12-19
Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
Columbia University
Phase 3 Withdrawn
NCT03553537 2018-06-12
Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Southwest Hospital, China
Phase 3 Unknown
NCT03023358 2017-01-18
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT00970385 2009-09-09
LTP
University Hospital, Grenoble
Phase 3 Completed